Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

BUY
$24.4 - $41.3 $99,064 - $167,678
4,060 New
4,060 $0
Q2 2022

Jul 27, 2022

SELL
$36.95 - $82.41 $159,254 - $355,187
-4,310 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$135.05 - $182.59 $1,350 - $1,825
10 Added 0.23%
4,310 $643,000
Q3 2021

Nov 05, 2021

SELL
$145.58 - $192.14 $509,530 - $672,490
-3,500 Reduced 44.87%
4,300 $630,000
Q2 2021

Aug 04, 2021

BUY
$134.22 - $202.37 $275,151 - $414,858
2,050 Added 35.65%
7,800 $1.53 Million
Q1 2021

May 14, 2021

SELL
$140.25 - $196.86 $1.12 Million - $1.57 Million
-8,000 Reduced 58.18%
5,750 $1.04 Million
Q4 2020

Feb 08, 2021

BUY
$126.47 - $163.7 $126,470 - $163,700
1,000 Added 7.84%
13,750 $1.95 Million
Q2 2020

Aug 03, 2020

BUY
$58.39 - $89.31 $744,472 - $1.14 Million
12,750 New
12,750 $1.14 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.07B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.